Gilead Sciences | Текущие Активы



Current Assets Изменить Дата
AbbVie USD 25.58B 2.2B 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
ALKERMES USD 1.42B 167.74M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.23B 7.24M 2025-03
J&J USD 71.55B 15.66B 2025-03
Merck USD 38.78B 1.58B 2024-12
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sanofi 44.02B 1.43B 2025-03
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Gilead Sciences Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.